UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-phase study tested a new drug (PF-07265028) alone or with another drug (sasanlimab) in people with advanced solid tumors like lung, stomach, and head/neck cancers. The goal was to find the safest dose and see if the drug shrinks tumors. The study was stopped early, and…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 01:04 UTC
-
Experimental bladder cancer drug combo shows promise but study halted early
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and to monitor side effects. The study included 348 participants b…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 01:04 UTC